Dr. Franco is an accomplished physician with a long career distinguished by renowned research, global teaching, speaking and collaboration, and a thriving medical practice at Massachusetts Eye and Ear, Harvard University. He is a co-founder of Reflux Gourmet.
Every person deserves the highest quality of healthcare.
This is my mantra…or was it my father’s? As I look back on my life, it becomes harder to distinguish where my calling began – because it is a calling that I share with my father. Did I carefully weigh the endless options for the many futures I could choose, or was it inevitable from the moment my dad started taking me to clinic with him that I, too, would pursue medicine? Was it ever a choice, or is it written in my DNA?
Whatever the reason, I am grateful for the result. In this special season of giving thanks, what I am most grateful for is the privilege I have of caring for others and the responsibility of their trust that I so cherish. My father showed me in word and deed that there is no more humbling a mantle.
The mantle of Medicine, like other scientific disciplines, is dynamic – changing when new information is discovered. After rigorous testing and peer review, those ideas that remain supplant the old ideas and are incorporated into the new and improved Medicine. Thus, determining what is “best,” what is “the highest quality of healthcare,” is a dance where the steps are constantly changing. A dance I have strived my entire career to ensure reflects the highest quality of healthcare for those who place their trust in me.
With this in mind, reflux has posed one of the trickiest problems facing my patients and my practice. I began my residency in Otolaryngology in 1995 and quickly learned that PPIs (proton pump inhibiting drugs) were the prescription of choice for the treatment of gastroesophageal reflux (GERD) and laryngopharyngeal reflux (LPR). By 1999, Prilosec became the first $5 billion prescription medication – and by 2002 it was above $10 billion! Based on the record-breaking sales figures alone, we must have been curing reflux like the plague, right? The scientific literature echoed these sentiments describing the key role PPI acid suppression therapy had in the treatment of reflux.
FILED UNDER: REFLUXGOURMET BLOG
What Drives Me
Dr. Franco is an accomplished physician with a long career distinguished by renowned research, global teaching, speaking and collaboration, and a thriving medical practice at Massachusetts Eye and Ear, Harvard University. He is a co-founder of Reflux Gourmet.
Every person deserves the highest quality of healthcare.
This is my mantra…or was it my father’s? As I look back on my life, it becomes harder to distinguish where my calling began – because it is a calling that I share with my father. Did I carefully weigh the endless options for the many futures I could choose, or was it inevitable from the moment my dad started taking me to clinic with him that I, too, would pursue medicine? Was it ever a choice, or is it written in my DNA?
Whatever the reason, I am grateful for the result. In this special season of giving thanks, what I am most grateful for is the privilege I have of caring for others and the responsibility of their trust that I so cherish. My father showed me in word and deed that there is no more humbling a mantle.
The mantle of Medicine, like other scientific disciplines, is dynamic – changing when new information is discovered. After rigorous testing and peer review, those ideas that remain supplant the old ideas and are incorporated into the new and improved Medicine. Thus, determining what is “best,” what is “the highest quality of healthcare,” is a dance where the steps are constantly changing. A dance I have strived my entire career to ensure reflects the highest quality of healthcare for those who place their trust in me.
With this in mind, reflux has posed one of the trickiest problems facing my patients and my practice. I began my residency in Otolaryngology in 1995 and quickly learned that PPIs (proton pump inhibiting drugs) were the prescription of choice for the treatment of gastroesophageal reflux (GERD) and laryngopharyngeal reflux (LPR). By 1999, Prilosec became the first $5 billion prescription medication – and by 2002 it was above $10 billion! Based on the record-breaking sales figures alone, we must have been curing reflux like the plague, right? The scientific literature echoed these sentiments describing the key role PPI acid suppression therapy had in the treatment of reflux.
